Drugs / Fluticasone Furoate/GW642444
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 3 | NCT01086410 Comparator | Mar → Sep 2010 | asthma | GlaxoSmithKline | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Fluticasone Furoate/GW642444 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01086410 ↗ |
| Route | Inhaled | “Dose B inhaled once daily for 6 weeks' treatment” NCT01086410 ↗ |